Cross Country Healthcare gains 6.2% as Aya deal clears FTC compliance hurdle.
PorAinvest
viernes, 5 de septiembre de 2025, 7:13 am ET1 min de lectura
CCRN--
The certification marks a significant milestone in the acquisition process, which was first announced on December 4, 2024. Initially, the deal was expected to close by September 3, 2025, but the termination date has been automatically extended to December 3, 2025 [2]. This extension allows the FTC additional time to complete its review, which is crucial for transactions of this scale in the healthcare staffing sector [3].
The merger, valued at approximately $615 million, would see Aya Healthcare acquire Cross Country for $18.61 per share in cash. Aya Healthcare, the largest healthcare staffing firm in the US, is expected to benefit from the acquisition of Cross Country, the seventh-largest healthcare staffing firm in the US [2].
The certification of compliance with the FTC's second request signifies progress in the regulatory review process and helps clarify the path to the expected Q4 2025 closing. Investors can expect further updates as the regulatory process continues, with the merger now anticipated to finalize in the fourth quarter of 2025, pending the satisfaction of customary closing conditions, including the remaining regulatory green lights [3].
References:
[1] https://seekingalpha.com/news/4492456-cross-country-health-gains-amid-certifying-compliance-with-ftc-for-avaya-deal
[2] https://www.staffingindustry.com/news/global-daily-news/aya-cross-country-extend-merger-deadline
[3] https://www.panabee.com/news/cross-country-healthcare-merger-update-end-date-shifts-to-december-as-ftc-review-progres
Cross Country Healthcare shares rose 6.2% after the company and Aya agreed to certify compliance with the Federal Trade Commission for their deal. The certification confirms that the companies have met the FTC's requirements for the acquisition, paving the way for the deal to be completed.
Cross Country Healthcare (NASDAQ: CCRN) saw its shares increase by 6.2% following the company's certification of compliance with the Federal Trade Commission (FTC) for its acquisition deal with Aya Healthcare. The certification, disclosed in an 8-K filing on September 1, 2025, indicates that both companies have substantially complied with the FTC's second request, a standard regulatory step in the review process for significant mergers [1].The certification marks a significant milestone in the acquisition process, which was first announced on December 4, 2024. Initially, the deal was expected to close by September 3, 2025, but the termination date has been automatically extended to December 3, 2025 [2]. This extension allows the FTC additional time to complete its review, which is crucial for transactions of this scale in the healthcare staffing sector [3].
The merger, valued at approximately $615 million, would see Aya Healthcare acquire Cross Country for $18.61 per share in cash. Aya Healthcare, the largest healthcare staffing firm in the US, is expected to benefit from the acquisition of Cross Country, the seventh-largest healthcare staffing firm in the US [2].
The certification of compliance with the FTC's second request signifies progress in the regulatory review process and helps clarify the path to the expected Q4 2025 closing. Investors can expect further updates as the regulatory process continues, with the merger now anticipated to finalize in the fourth quarter of 2025, pending the satisfaction of customary closing conditions, including the remaining regulatory green lights [3].
References:
[1] https://seekingalpha.com/news/4492456-cross-country-health-gains-amid-certifying-compliance-with-ftc-for-avaya-deal
[2] https://www.staffingindustry.com/news/global-daily-news/aya-cross-country-extend-merger-deadline
[3] https://www.panabee.com/news/cross-country-healthcare-merger-update-end-date-shifts-to-december-as-ftc-review-progres

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios